- Home
- RLMD vs WENN Comparison
RLMD vs WENN Comparison
Compare RLMD & WENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLMD | WENN |
|---|---|---|
| Founded | 2004 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.8M | 390.2M |
| IPO Year | 2012 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RLMD | WENN |
|---|---|---|
| Price | $3.25 | $10.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.75 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 352.6K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $2.15 | $10.09 |
| 52 Week High | $8.00 | $10.44 |
Technical Indicators
Market Signals| Indicator | RLMD | WENN |
|---|---|---|
| Relative Strength Index (RSI) | 38.09 | 73.05 |
| Support Level | $3.13 | $10.41 |
| Resistance Level | $3.55 | N/A |
| Average True Range (ATR) | 0.20 | 0.01 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 32.28 | 100.00 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
About WENN Wen Acquisition Corp Class A Ordinary Shares
Wen Acquisition Corp is a blank check company.